1. Home
  2. ATMU vs CRSP Comparison

ATMU vs CRSP Comparison

Compare ATMU & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atmus Filtration Technologies Inc.

ATMU

Atmus Filtration Technologies Inc.

HOLD

Current Price

$55.43

Market Cap

4.3B

ML Signal

HOLD

Logo CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

HOLD

Current Price

$56.49

Market Cap

5.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATMU
CRSP
Founded
1958
2013
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
5.1B
IPO Year
2023
2016

Fundamental Metrics

Financial Performance
Metric
ATMU
CRSP
Price
$55.43
$56.49
Analyst Decision
Buy
Buy
Analyst Count
4
19
Target Price
$49.50
$71.50
AVG Volume (30 Days)
569.3K
1.7M
Earning Date
02-20-2026
02-10-2026
Dividend Yield
0.40%
N/A
EPS Growth
11.13
N/A
EPS
2.39
N/A
Revenue
$1,724,400,000.00
$38,337,000.00
Revenue This Year
$6.37
N/A
Revenue Next Year
$4.11
$718.51
P/E Ratio
$23.08
N/A
Revenue Growth
3.72
N/A
52 Week Low
$30.94
$30.04
52 Week High
$55.78
$78.48

Technical Indicators

Market Signals
Indicator
ATMU
CRSP
Relative Strength Index (RSI) 65.80 51.43
Support Level $51.76 $53.37
Resistance Level $55.13 $60.73
Average True Range (ATR) 1.21 2.33
MACD 0.09 0.12
Stochastic Oscillator 94.04 47.39

Price Performance

Historical Comparison
ATMU
CRSP

About ATMU Atmus Filtration Technologies Inc.

Atmus Filtration Technologies Inc manufactures filtration products for on-highway commercial vehicles and off-highway agriculture, construction, mining, and power generation vehicles and equipment. The company designs and manufactures Developed filtration products, principally under the Fleetguard brand, that enable lower emissions and provide asset protection. The company designs, manufactures, and sells filters, coolants, and chemical products. The company offers products including air filtration, coolants and chemicals, crankcase ventilation, fuel filtration, fuel cells, lube filtration, and others.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: